Rosmantuzumab
Rosmantuzumab
Main page

Rosmantuzumab

logo
Community Hub0 subscribers
What are your thoughts?
Be the first to start a discussion here.
Be the first to start a discussion here.
Rosmantuzumab

Rosmantuzumab (INN; development code OMP-131R10) is a humanized monoclonal antibody designed for the treatment of cancer.

This drug was developed by OncoMed Pharmaceuticals.

See all
User Avatar
No comments yet.